BioLife Solutions Price to Book Ratio 2010-2025 | BLFS
Historical price to book ratio values for BioLife Solutions (BLFS) over the last 10 years. The current price to book ratio for BioLife Solutions as of July 18, 2025 is 2.89.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| BioLife Solutions Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2025-07-18 | 20.83 | 2.81 | |
| 2025-03-31 | 22.84 | $7.42 | 3.08 |
| 2024-12-31 | 25.96 | $7.44 | 3.49 |
| 2024-09-30 | 25.04 | $7.04 | 3.56 |
| 2024-06-30 | 21.43 | $6.97 | 3.07 |
| 2024-03-31 | 18.55 | $7.30 | 2.54 |
| 2023-12-31 | 16.25 | $7.48 | 2.17 |
| 2023-09-30 | 13.81 | $7.57 | 1.82 |
| 2023-06-30 | 22.10 | $8.11 | 2.73 |
| 2023-03-31 | 21.75 | $8.27 | 2.63 |
| 2022-12-31 | 18.20 | $8.50 | 2.14 |
| 2022-09-30 | 22.75 | $9.56 | 2.38 |
| 2022-06-30 | 13.81 | $9.69 | 1.42 |
| 2022-03-31 | 22.73 | $11.30 | 2.01 |
| 2021-12-31 | 37.27 | $11.43 | 3.26 |
| 2021-09-30 | 42.32 | $11.81 | 3.58 |
| 2021-06-30 | 44.51 | $11.15 | 3.99 |
| 2021-03-31 | 36.00 | $6.21 | 5.80 |
| 2020-12-31 | 39.89 | $6.21 | 6.42 |
| 2020-09-30 | 28.94 | $5.82 | 4.98 |
| 2020-06-30 | 16.35 | $4.07 | 4.01 |
| 2020-03-31 | 9.50 | $3.20 | 2.97 |
| 2019-12-31 | 16.18 | $2.09 | 7.75 |
| 2019-09-30 | 16.63 | $3.78 | 4.39 |
| 2019-06-30 | 16.95 | $2.45 | 6.92 |
| 2019-03-31 | 17.89 | $2.37 | 7.55 |
| 2018-12-31 | 12.03 | $0.79 | 15.25 |
| 2018-09-30 | 17.50 | $2.41 | 7.27 |
| 2018-06-30 | 11.41 | $1.22 | 9.35 |
| 2018-03-31 | 5.13 | $0.74 | 6.93 |
| 2017-12-31 | 6.00 | $0.72 | 8.34 |
| 2017-09-30 | 5.71 | $0.54 | 10.55 |
| 2017-06-30 | 2.39 | $0.52 | 4.63 |
| 2017-03-31 | 2.09 | $0.22 | 9.70 |
| 2016-12-31 | 1.61 | $0.25 | 6.54 |
| 2016-09-30 | 1.84 | $0.52 | 3.57 |
| 2016-06-30 | 1.60 | $0.60 | 2.67 |
| 2016-03-31 | 1.83 | $0.68 | 2.68 |
| 2015-12-31 | 2.17 | $0.79 | 2.74 |
| 2015-09-30 | 2.11 | $0.89 | 2.38 |
| 2015-06-30 | 1.95 | $0.98 | 2.00 |
| 2015-03-31 | 1.61 | $1.06 | 1.52 |
| 2014-12-31 | 1.64 | $1.15 | 1.42 |
| 2014-09-30 | 2.10 | $1.05 | 2.00 |
| 2014-06-30 | 2.28 | $1.11 | 2.05 |
| 2014-03-31 | 3.69 | $1.18 | 3.13 |
| 2013-12-31 | 8.40 | $-2.64 | -3.18 |
| 2013-09-30 | 11.13 | $-2.56 | -4.35 |
| 2013-06-30 | 5.04 | $-2.53 | -1.99 |
| 2013-03-31 | 4.06 | $-2.48 | -1.64 |
| 2012-12-31 | 4.76 | $-2.51 | -1.90 |
| 2012-09-30 | 1.82 | $-2.42 | -0.75 |
| 2012-06-30 | 1.26 | $-2.36 | -0.53 |
| 2012-03-31 | 1.40 | $-2.30 | -0.61 |
| 2011-12-31 | 0.70 | $-2.25 | -0.31 |
| 2011-09-30 | 1.12 | $-2.18 | -0.51 |
| 2011-06-30 | 1.12 | $-2.11 | -0.53 |
| 2011-03-31 | 1.12 | $-2.03 | -0.55 |
| 2010-12-31 | 0.77 | $-1.92 | -0.40 |
| 2010-09-30 | 1.19 | $-1.85 | -0.64 |
| 2010-06-30 | 1.33 | $-1.77 | -0.75 |
| 2010-03-31 | 1.41 | $-1.67 | -0.85 |
| 2009-12-31 | 1.54 | $-1.57 | -0.98 |
| 2009-09-30 | 1.82 | $-1.51 | -1.21 |
| 2009-06-30 | 2.38 | $-1.40 | -1.70 |
| 2009-03-31 | 0.70 | $-1.20 | -0.58 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.025B | $0.082B |
| BioLife Solutions has pioneered the next generation of preservation solutions designed to maintain the viability and health of cellular matter and tissues during freezing, transportation and storage. Based on their proprietary bio-packaging technology and a patented understanding of the mechanism of cellular damage and death, these products enable the biotechnology and medical community to address a growing problem that exists today. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $209.668B | 24.59 |
| Boston Scientific (BSX) | United States | $154.824B | 38.76 |
| Stryker (SYK) | United States | $148.439B | 31.04 |
| EssilorLuxottica (ESLOY) | France | $131.494B | 0.00 |
| Medtronic (MDT) | Ireland | $114.826B | 16.28 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.743B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.081B | 24.59 |
| ResMed (RMD) | United States | $37.598B | 28.24 |
| GE HealthCare Technologies (GEHC) | United States | $34.909B | 16.57 |
| Agilent Technologies (A) | United States | $33.054B | 21.55 |
| Terumo (TRUMY) | Japan | $24.345B | 31.62 |
| Koninklijke Philips (PHG) | Netherlands | $23.697B | 16.63 |
| Insulet (PODD) | United States | $19.948B | 78.30 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.776B | 12.06 |
| Baxter (BAX) | United States | $14.312B | 10.69 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.087B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
| Demant (WILYY) | Denmark | $8.633B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.794B | 23.64 |
| Lantheus Holdings (LNTH) | United States | $5.092B | 12.85 |
| Perrigo (PRGO) | Ireland | $3.733B | 9.46 |
| Prestige Consumer Healthcare (PBH) | United States | $3.713B | 16.58 |
| Haemonetics (HAE) | United States | $3.529B | 16.07 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.347B | 27.82 |
| ICU Medical (ICUI) | United States | $3.070B | 22.64 |
| LeMaitre Vascular (LMAT) | United States | $1.855B | 41.47 |
| QuidelOrtho (QDEL) | United States | $1.804B | 12.41 |
| AtriCure (ATRC) | United States | $1.473B | 0.00 |
| Acuren (TIC) | United States | $1.444B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.242B | 12.60 |
| Green Thumb Industries (GTBIF) | United States | $1.207B | 27.14 |
| Phibro Animal Health (PAHC) | United States | $1.205B | 15.40 |
| Neogen (NEOG) | United States | $1.055B | 13.50 |
| InMode (INMD) | Israel | $0.891B | 8.98 |
| Kestra Medical Technologies (KMTS) | United States | $0.845B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.674B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.639B | 0.00 |
| Owens & Minor (OMI) | United States | $0.617B | 5.12 |
| Tilray Brands (TLRY) | Canada | $0.615B | 0.00 |
| Evolus (EOLS) | United States | $0.602B | 0.00 |
| CeriBell (CBLL) | United States | $0.565B | 0.00 |
| Valneva SE (VALN) | France | $0.553B | 0.00 |
| Surmodics (SRDX) | United States | $0.438B | 0.00 |
| SNDL (SNDL) | Canada | $0.410B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.327B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.323B | 11.89 |
| Sanuwave Health (SNWV) | United States | $0.321B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.304B | 0.00 |
| Quanterix (QTRX) | United States | $0.275B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.270B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.264B | 22.23 |
| Cerus (CERS) | United States | $0.262B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.256B | 75.83 |
| OraSure Technologies (OSUR) | United States | $0.245B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.244B | 0.00 |
| ZimVie (ZIMV) | United States | $0.241B | 10.96 |
| Biote (BTMD) | United States | $0.228B | 6.42 |
| Brainsway (BWAY) | Israel | $0.219B | 58.05 |
| Verano Holdings (VRNOF) | United States | $0.204B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.204B | 0.00 |
| Omeros (OMER) | United States | $0.204B | 0.00 |
| High Tide (HITI) | Canada | $0.203B | 0.00 |
| Organigram Global (OGI) | Canada | $0.196B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.182B | 14.82 |
| TriSalus Life Sciences (TLSI) | United States | $0.179B | 0.00 |
| Exagen (XGN) | United States | $0.153B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.150B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.125B | 15.33 |
| TerrAscend (TSNDF) | Canada | $0.107B | 0.00 |
| Jin Medical (ZJYL) | China | $0.101B | 0.00 |
| Fonar (FONR) | United States | $0.099B | 12.74 |
| MacroGenics (MGNX) | United States | $0.097B | 0.00 |
| Veru (VERU) | United States | $0.090B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.090B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Apyx Medical (APYX) | United States | $0.086B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.081B | 0.00 |
| Zynex (ZYXI) | United States | $0.071B | 0.00 |
| Agape ATP (ATPC) | $0.071B | 0.00 | |
| InterCure (INCR) | Israel | $0.068B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.062B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 0.00 |
| Safety Shot (SHOT) | United States | $0.052B | 0.00 |
| United-Guardian (UG) | United States | $0.042B | 14.54 |
| Nephros (NEPH) | United States | $0.038B | 51.14 |
| Modular Medical (MODD) | United States | $0.038B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.037B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.022B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Senestech (SNES) | United States | $0.011B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |